miR-27A is downregulated in bladder cancer tissue samples and is involved in enhancing cisplatin resistance by regulating the expression of Solute Carrier Family 7 Member 11 (SLC7A11). This evidence concerns the gene SLC7A11 and urinary bladder cancer.